Skip to main content

Articles

Page 8 of 9

  1. Good communication is central to a high-quality consultation process. We assessed the quality of referral information from primary care physicians (PCPs) to rheumatologists and the quality and timeliness of co...

    Authors: Jenna Wong, Karen Tu, Sasha Bernatsky, Liisa Jaakkimainen, J. Carter Thorne, Vandana Ahluwalia, J. Michael Paterson and Jessica Widdifield
    Citation: BMC Rheumatology 2019 3:23

    The Publisher Correction to this article has been published in BMC Rheumatology 2019 3:35

  2. Around 1 in 8 patients with axial spondyloarthritis (axSpA) also meet criteria for fibromyalgia and such patients have considerable unmet need. Identifying effective therapy is important but to what extent fib...

    Authors: Gary J. Macfarlane, Ejaz Pathan, Stefan Siebert, Jonathan Packham, Karl Gaffney, Ernest Choy, Raj Sengupta, Fabiola Atzeni, Kathryn R. Martin, Gareth T. Jones and Linda E. Dean
    Citation: BMC Rheumatology 2019 3:19
  3. With improved therapies and management, more women with inflammatory arthritides (IA) are considering pregnancy. Our objective was to survey rheumatologists across Canada about their IA management in pregnancy...

    Authors: Mary A. De Vera, Corisande Baldwin, Nicole W. Tsao, Alyssa Howren, Glen S. Hazlewood, Nevena Rebić and Stephanie Ensworth
    Citation: BMC Rheumatology 2019 3:18
  4. Adjusting medication of patients with rheumatoid arthritis (RA) until predefined disease activity targets are met, i.e. Treat-to-Target (T2T), is the currently recommended treatment approach. However, not much...

    Authors: Celine J. van de Laar, Martijn A. H. Oude Voshaar and Harald E. Vonkeman
    Citation: BMC Rheumatology 2019 3:16
  5. The details of two rheumatoid arthritis (RA) patients with systemic sclerosis (SSc) who were administered tocilizumab, an anti-interleukin-6 receptor antibody, are reported, along with a review of the literature.

    Authors: Hiroki Wakabayashi, Hitoshi Kino, Makoto Kondo, Keiichi Yamanaka, Masahiro Hasegawa and Akihiro Sudo
    Citation: BMC Rheumatology 2019 3:15
  6. The pathobiology of rheumatoid arthritis (RA) is similar to that of periodontitis in that proinflammatory cytokines play an important pathologic role. There is evidence to suggest that inhibitors of tumor necr...

    Authors: Tetsuo Kobayashi, Satoshi Ito, Akira Murasawa, Hajime Ishikawa and Hiromasa Yoshie
    Citation: BMC Rheumatology 2019 3:13
  7. The TITRATE trial seeks to test whether intensive management is valuable in achieving disease remission in moderately active rheumatoid arthritis. Intensive management is a complex intervention consisting of: ...

    Authors: Louise Prothero, Jackie Sturt, Savia de Souza and Heidi Lempp
    Citation: BMC Rheumatology 2019 3:12
  8. Uncontrolled gout can cause significant joint and organ damage and has been associated with impairments in quality of life and high economic cost. Gout has also been associated with other comorbid diseases, su...

    Authors: Dena H. Jaffe, Alyssa B. Klein, Arriel Benis, Natalia M. Flores, Hagit Gabay, Robert Morlock, Dana Y. Teltsch, Jonathan Chapnick, Yair Molad, Shmuel M. Giveon, Becca Feldman and Maya Leventer-Roberts
    Citation: BMC Rheumatology 2019 3:11
  9. Inhibitors of tumor necrosis factor alpha (TNF-α) are current mainstay of therapies for rheumatoid arthritis (RA). The decision when to withdraw TNF-α inhibitors after achieving remission and the incidence of ...

    Authors: Arduino A. Mangoni, Fahdah Al Okaily, Hani Almoallim, Seham Al Rashidi, Reem Hamdy A. Mohammed and Amal Barbary
    Citation: BMC Rheumatology 2019 3:10
  10. Anti-neutrophil cytoplasmic antibodies associated vasculitides (AAV) are characterized by autoimmune small vessel inflammation. Eosinophils are multifunctional cells with both pro-inflammatory and immunoregula...

    Authors: Thomas Hellmark, Sophie Ohlsson, Ã…sa Pettersson, Markus Hansson and Ã…sa C. M. Johansson
    Citation: BMC Rheumatology 2019 3:9
  11. Signs and symptoms establish the diagnosis of adult onset Still’s disease (AOSD) as well as of systemic onset juvenile idiopathic arthritis (sJIA). The published data regarding the importance of IL-18 as a mar...

    Authors: Holger Kudela, Susanne Drynda, Anke Lux, Gerd Horneff and Joern Kekow
    Citation: BMC Rheumatology 2019 3:4
  12. The emphasis on treating rheumatoid arthritis (RA) intensively reduces disease activity but its impact in routine care is uncertain. We evaluated temporal changes in disease activities and outcomes in a 10-yea...

    Authors: Nicola J. Gullick, Fowzia Ibrahim, Ian C. Scott, Alexandra Vincent, Andrew P. Cope, Toby Garrood, Gabriel S. Panayi, David L. Scott and Bruce W. Kirkham
    Citation: BMC Rheumatology 2019 3:6
  13. Hemophagocytic lymphohistiocytosis (HLH) is a severe clinical entity associated with high mortality in the adult population. HLH has been associated with infections, malignancy and autoimmune conditions such a...

    Authors: Christina S. Thornton, Parham Minoo, Michelle Schneider and Aurore Fifi-Mah
    Citation: BMC Rheumatology 2019 3:7
  14. Rheumatoid arthritis is an autoimmune disease that causes joint inflammation. It affects around 400,000 people in the UK and 1 million adults in the USA. Given the appropriate treatment, many can have relative...

    Authors: Fran Toye, Kate Seers and Karen Louise Barker
    Citation: BMC Rheumatology 2019 3:5
  15. Biomarkers of rheumatoid arthritis (RA) disease activity typically measure inflammation or autoimmunity (e.g. CRP, RF). C1M and C3M, metabolites of type I and III collagen, are markers reflecting tissue metabo...

    Authors: Anne C. Bay-Jensen, Adam Platt, Martin A. Jenkins, Michael E. Weinblatt, Inger Byrjalsen, Kishwar Musa, Mark C. Genovese and Morten A. Karsdal
    Citation: BMC Rheumatology 2019 3:3
  16. Fibromyalgia is characterized by chronic generalized pain, fatigue, sleep disorders and other symptoms. Physical exercise is recommended as the first choice of non-pharmacological therapy. Thus, the aim of thi...

    Authors: Katherinne Ferro Moura Franco, Yuri Rafael dos Santos Franco, Evany Maira Espírito Santo Salvador, Bruna Cristina Brajon do Nascimento, Gisela Cristiane Miyamoto and Cristina Maria Nunes Cabral
    Citation: BMC Rheumatology 2019 3:2
  17. Tumour necrosis factor inhibitor (TNFi) therapy has been available for rheumatoid arthritis (RA) patients for several decades but data on the long-term risk of malignancy associated with its use is limited. Ou...

    Authors: Margaret P. Staples, Lyn March, Catherine Hill, Marissa Lassere and Rachelle Buchbinder
    Citation: BMC Rheumatology 2019 3:1
  18. Fibromyalgia (FM) is a complex, centralized pain condition that is often difficult to diagnose and treat. FM is considered to have a genetic background due to its familial aggregation and due to findings from ...

    Authors: Chee Lee, Ginevra Liptan, Svetlana Kantorovich, Maneesh Sharma and Ashley Brenton
    Citation: BMC Rheumatology 2018 2:38
  19. Autoimmune disorders are known to produce false positives in serological tests for infections. Aetiological association between infections and autoimmunity, increased susceptibility to infectious and autoimmun...

    Authors: Harsha Anuruddhika Dissanayake, Gayani Premawansa, Enoka Corea and Inoshi Atukorale
    Citation: BMC Rheumatology 2018 2:37
  20. To investigate the incidence and the mortality-rates of systemic sclerosis (SSc), its primary causes of death, and the temporal trends in events in Denmark during the last decades.

    Authors: Sheraz A. Butt, Jørgen L. Jeppesen, Christine Fuchs, Mette Mogensen, Merete Engelhart, Christian Torp-Pedersen, Gunnar H. Gislason, Søren Jacobsen and Charlotte Andersson
    Citation: BMC Rheumatology 2018 2:36
  21. To understand the roles of serum exosomes in rheumatoid arthritis (RA), we comprehensively investigated the protein profiles of serum exosomes in patients with RA.

    Authors: Hirotaka Tsuno, Mitsumi Arito, Naoya Suematsu, Toshiyuki Sato, Atsushi Hashimoto, Toshihiro Matsui, Kazuki Omoteyama, Masaaki Sato, Kazuki Okamoto, Shigeto Tohma, Manae S. Kurokawa and Tomohiro Kato
    Citation: BMC Rheumatology 2018 2:35
  22. The pathogenesis of spondyloarthritis (SpA) involves both inflammation and new bone formation in the spine. In line with this, the disease has been characterized as both inflammatory and fibrotic. The current ...

    Authors: Julie Stougaard, Søren Lomholt, Pernille Ommen, Jens Kelsen and Tue W. Kragstrup
    Citation: BMC Rheumatology 2018 2:33
  23. There is increasing interest in the identification of people at risk of rheumatoid arthritis (RA) to monitor the emergence of early symptoms (and thus allow early therapy), offer lifestyle advice to reduce the...

    Authors: Gwenda Simons, Rebecca J Stack, Michaela Stoffer-Marx, Matthias Englbrecht, Erika Mosor, Christopher D Buckley, Kanta Kumar, Mats Hansson, Axel Hueber, Tanja Stamm, Marie Falahee and Karim Raza
    Citation: BMC Rheumatology 2018 2:31
  24. We report the case of a patient with rheumatoid arthritis (RA) treated with tofacitinib who developed severe Pneumocystis jirovecii pneumonia (PJP) with an atypical clinical presentation.

    Authors: Ian F. J. Pirker, Jacqueline Krane-Nuber, Werner C. Albrich, Rüdiger Müller and Thomas Neumann
    Citation: BMC Rheumatology 2018 2:34
  25. Osteoarthritis (OA) is diagnosed and managed primarily by general practitioners (GPs). OA guidelines recommend using clinical criteria, without x-ray, for diagnosis, and advising strengthening exercise, aerobi...

    Authors: Thorlene Egerton, Rachel K Nelligan, Jenny Setchell, Lou Atkins and Kim L Bennell
    Citation: BMC Rheumatology 2018 2:30
  26. Resveratrol is a natural polyphenol found in berries, roots and wine that is well known to have anti-inflammatory and anti-oxidative properties. The anti-inflammatory effect has been reported for both immune c...

    Authors: S. Lomholt, A. Mellemkjaer, M. B. Iversen, S. B. Pedersen and T. W. Kragstrup
    Citation: BMC Rheumatology 2018 2:27
  27. Fibromyalgia is a debilitating condition, characterized by extensive muscular pain and fatigue. Vitamin D is essential for overall health, with ubiquitous involvement in various inflammatory and pain pathways....

    Authors: Shawn D. Ellis, Sam T. Kelly, Jonathan H. Shurlock and Alastair L. N. Hepburn
    Citation: BMC Rheumatology 2018 2:28
  28. To evaluate demographics, family history, and previous medication use at enrollment in a subset of psoriasis patients with self-reported psoriatic arthritis (PsA) enrolled in Psoriasis Longitudinal Assessment ...

    Authors: Arthur Kavanaugh, Kim Papp, Alice B. Gottlieb, Elke M. G. J. de Jong, Soumya D. Chakravarty, Shelly Kafka, Wayne Langholff, Kamyar Farahi, Bhaskar Srivastava and Jose U. Scher
    Citation: BMC Rheumatology 2018 2:29
  29. Vitamin D has been implicated as being involved in the aetio-pathogenesis of several autoimmune diseases including rheumatoid arthritis (RA). Previous studies present contradictory results. Vitamin D binding p...

    Authors: Mikael Brink, Linda Johansson, Evelina Nygren, Lisbeth Ärlestig, Johan Hultdin and Solbritt Rantapää-Dahlqvist
    Citation: BMC Rheumatology 2018 2:26
  30. Chronic inflammatory arthritis is associated with increased cardiovascular (CV) morbidity and mortality. Pharmacological management and healthy lifestyle modification is recommended to manage these risks, but ...

    Authors: Premarani Sinnathurai, Alexandra Capon, Rachelle Buchbinder, Vibhasha Chand, Lyndall Henderson, Marissa Lassere and Lyn March
    Citation: BMC Rheumatology 2018 2:25
  31. Anti-cytokine therapies such as adalimumab, tocilizumab, and the small molecule JAK inhibitor tofacitinib have proven that cytokines and their subsequent downstream signaling processes are important in the pat...

    Authors: Julie M. Parmentier, Jeff Voss, Candace Graff, Annette Schwartz, Maria Argiriadi, Michael Friedman, Heidi S. Camp, Robert J. Padley, Jonathan S. George, Deborah Hyland, Matthew Rosebraugh, Neil Wishart, Lisa Olson and Andrew J. Long
    Citation: BMC Rheumatology 2018 2:23
  32. Although psoriatic arthritis is complex and involves multiple domains, recent advances in treatments have made remission or near-remission of most symptoms a potentially achievable goal for many patients. We s...

    Authors: Laura C. Coates, Ana-Maria Orbai, Akimichi Morita, Olivier Benichou, Lisa Kerr, David H. Adams, Catherine L. Shuler, Julie Birt and Philip S. Helliwell
    Citation: BMC Rheumatology 2018 2:24
  33. Autoimmune rheumatic diseases (ARDs) such as inflammatory arthritis and Lupus, and many of the treatments for these diseases, can have a detrimental impact on fertility and pregnancy outcomes. Disease activity...

    Authors: Rhiannon Phillips, Bethan Pell, Aimee Grant, Daniel Bowen, Julia Sanders, Ann Taylor, Adrian Edwards, Ernest Choy and Denitza Williams
    Citation: BMC Rheumatology 2018 2:21
  34. Takayasu arteritis is a rare large vessel vasculitis which predominantly affects young Asian females. Aortic regurgitation and heart failure are well described manifestations which are usually preceded by cons...

    Authors: Nipun Lakshitha de Silva, Milinda Withana, Praveen Weeratunga, Prakash Priyadharshana and Inoshi Atukorala
    Citation: BMC Rheumatology 2018 2:20
  35. There is growing evidence that it may be possible to identify people at high risk of developing rheumatoid arthritis (RA). Assuming that effective interventions were available, this could mean that treatments ...

    Authors: Sarah Munro, Luke Spooner, Katherine Milbers, Marie Hudson, Cheryl Koehn and Mark Harrison
    Citation: BMC Rheumatology 2018 2:18
  36. Behcet’s disease and Sjogren’s syndrome is an autoimmune disorder from which many systems of the body can suffer. Here we reported a patient with a history of Behcet’s disease and Sjogren’s syndrome in which R...

    Authors: Fulong Xiao, Jun Zhang, Waner Wang, Xuehua Wang, Wei Zhang, Liyue Xu and Fang Han
    Citation: BMC Rheumatology 2018 2:19
  37. Clinical response and remission are defined in multiple ways and measured with different instruments, resulting in substantial variation of the proportion of patients classified as being in remission. Therefor...

    Authors: Samina A. Turk, Linda A. Rasch, Dirkjan van Schaardenburg, Willem F. Lems, Marjolein Sanberg, Lilian H. D. van Tuyl and Marieke M. ter Wee
    Citation: BMC Rheumatology 2018 2:16
  38. Patients with metabolic syndrome (MetS) are at increased risk of asymptomatic hyperuricemia (i.e., elevated serum uric acid (SUA) level without gout) and cardiovascular disease. We conducted a cross-sectional ...

    Authors: Seoyoung C. Kim, Marcelo F. Di Carli, Rajesh K. Garg, Kathleen Vanni, Penny Wang, Alyssa Wohlfahrt, Zhi Yu, Fengxin Lu, Anarosa Campos, Courtney F. Bibbo, Stacy Smith and Daniel H. Solomon
    Citation: BMC Rheumatology 2018 2:17
  39. This study aimed to explore the beliefs of people with knee osteoarthritis (OA) about the disease, and how these beliefs had formed and what impact these beliefs had on activity participation, health behaviour...

    Authors: Ben Darlow, Melanie Brown, Bronwyn Thompson, Ben Hudson, Rebecca Grainger, Eileen McKinlay and J. Haxby Abbott
    Citation: BMC Rheumatology 2018 2:15
  40. This study analyzed visits for and factors associated with gout and gout medication treatment trends for the years 2007–2011 in the United States given the introduction of febuxostat, the first new treatment o...

    Authors: Kristen E. Castro, Kaitlyn D. Corey, Diana L. Raymond, Michael R. Jiroutek and Melissa A. Holland
    Citation: BMC Rheumatology 2018 2:14
  41. Systemic Sclerosis is a multifactorial autoimmune rheumatic disease characterized by inflammation, fibrosis, immune dysregulation and vascular dysfunction.

    Authors: Annemarie Schorpion, Max Shenin, Robin Neubauer and Chris T. Derk
    Citation: BMC Rheumatology 2018 2:13
  42. Cardiovascular disease (CVD) is markedly increased in patients with rheumatoid arthritis partly due to accelerated atherosclerosis from chronic inflammation. Traditional cardiovascular risk factors such as hyp...

    Authors: Aprajita Jagpal and Iris Navarro-Millán
    Citation: BMC Rheumatology 2018 2:10
  43. Pneumococcal vaccination is recommended to patients with rheumatoid arthritis (RA) and primary Sjögren’s syndrome (pSS). However, little is known whether the diseases influence pneumococcal vaccine response. T...

    Authors: Per Nived, Tore Saxne, Pierre Geborek, Thomas Mandl, Lillemor Skattum and Meliha C. Kapetanovic
    Citation: BMC Rheumatology 2018 2:12
  44. Chronic pain, regional or widespread, is a frequent and multidimensional symptom in arthritis. There is still limited information on chronic pain in spondyloarthritis, which is important to recognize for adequ...

    Authors: Elisabeth Mogard, Ann Bremander, Elisabet Lindqvist and Stefan Bergman
    Citation: BMC Rheumatology 2018 2:11
  45. Pharmacotherapy is paramount to the management of systemic autoimmune rheumatic diseases (SARDs), yet there is sub-optimal adherence and limited adherence interventions. To understand how to better support pat...

    Authors: Hans Haag, Tim Liang, J. Antonio Avina-Zubieta and Mary A. De Vera
    Citation: BMC Rheumatology 2018 2:9
  46. DAS28 is interpreted as the inflammatory disease activity of RA. Non-inflammatory pain mechanisms can confound assessment. We aimed to examine the use of DAS28 components or DAS28-derived measures that have be...

    Authors: Daniel F. McWilliams, Patrick D. W. Kiely, Adam Young, Nalinie Joharatnam, Deborah Wilson and David A. Walsh
    Citation: BMC Rheumatology 2018 2:8
  47. Systemic lupus erythematosus (SLE) is an autoimmune inflammatory disease which involves the loss of self-tolerance with hyperactivation of autoreactive T- and B-cells. Protein tyrosine phosphatase non-receptor...

    Authors: Adel M. Al-Awadhi, Mohammad Z. Haider, Jalaja Sukumaran and Sowmya Balakrishnan
    Citation: BMC Rheumatology 2018 2:7

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.1
    5-year Journal Impact Factor: 2.5
    Source Normalized Impact per Paper (SNIP): 0.776
    SCImago Journal Rank (SJR): 0.805

    Speed 2023
    Submission to first editorial decision (median days): 15
    Submission to acceptance (median days): 247

    Usage 2023
    Downloads: 398,220
    Altmetric mentions: 294

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal